UN / HIV VACCINE
20-Jul-2009
00:01:27
A new United Nations-backed report on investment in HIV prevention research in 2008 finds that funding levels for a possible vaccine for the virus have decreased for the first time since investment trends have been tracked. FILE
Subject to the Terms of Usages of UNifeed, UNifeed materials are available free of charge for news purposes only. UNifeed materials may not be sold or redistributed to third parties without the prior written consent of the UN or the UN entity which is source of the UNifeed material. All users of UNifeed materials must provide due credit to the United Nations or any UN entity source(s) in their use and broadcast of UNifeed materials.
Size
Format
Acquire
DESCRIPTION
STORY: HIV / VACCINE
TRT: 1.27
SOURCE: UNICEF / UNDP / WORLD BANK
RESTRICTIONS: NONE
LANGUAGE: NATS
DATELINE: FILE
TRT: 1.27
SOURCE: UNICEF / UNDP / WORLD BANK
RESTRICTIONS: NONE
LANGUAGE: NATS
DATELINE: FILE
SHOTLIST
FILE – UNICEF - DECEMBER 2008, LESOTHO
1. Wide shot, exterior HIV prevention banner
2. Close up, HIV prevention banner
3. Wide shot, HIV prevention poster
4. Wide shot, street
5. Close up, hospital plate
6. Wide shot, exterior Queen Elizabeth II hospital
7. Med shot, nurse filling out medical cards
8. Close up, nurse writing
FILE – UNICEF - 23-25 NOVEMBER 2008, DOUALA AND YAOUNDE, CAMEROON
9. Wide shot, giving medicine to son
10. Close up, son taking medicine
11. Wide shot, son taking medicine
12. Close up, son drinking water
13. Med shot, preparing medicine
14. Wide shot, giving medicine
15. Close up, son taking medicine
FILE - UNDP - 27-29 NOVEMBER 2008
16. Wide shot, VCT center
17. Close up, medical technician checking blood samples
18. Close up, HIV rapid testing kits
19. Med shot, medical technician doing tests
20. Med shot, people living with Aids chatting
21. Close up, counselor talking to the group
22. Med shot, members of the group people living with Aids
FILE – WORLD BANK 2007, MOZAMBIQUE
23. Various shots, lab with doctors
24. Tracking shot, hallway with people sitting, waiting for treatment
25. Various shots, nurse and patients
SHOTLIST:
A new United Nations-backed report on investment in HIV prevention research in 2008 finds that funding levels for a possible vaccine for the virus have decreased for the first time since investment trends have been tracked.
The report, “Adapting to Realities: Trends in HIV Prevention Research Funding 2000 to 2008”, notes that this trend may have been influenced by shifts in scientific priorities, the global economic downturn and competition for various health issues.
Despite the decrease, the overall trend since 2000 has been of greater investment for experimental biomedical prevention strategies, adds the report, prepared by the HIV Vaccine and Microbicide Resource Tracking Working Group, of which the Joint UN Program on HIV/AIDS (UNAIDS) is a member.
It identifies investments of almost $1.2 billion in HIV prevention research in 2008, of which $868 million supported vaccine research and development (R&D), and $244 million supported microbicide R&D.
The United States was once again the leader in funding HIV prevention research, supporting 71 per cent of HIV vaccine R&D and 63 per cent of microbicide R&D in 2008.
A recent report from UNAIDS and the World Bank warned that the well-being of millions of people could be p
1. Wide shot, exterior HIV prevention banner
2. Close up, HIV prevention banner
3. Wide shot, HIV prevention poster
4. Wide shot, street
5. Close up, hospital plate
6. Wide shot, exterior Queen Elizabeth II hospital
7. Med shot, nurse filling out medical cards
8. Close up, nurse writing
FILE – UNICEF - 23-25 NOVEMBER 2008, DOUALA AND YAOUNDE, CAMEROON
9. Wide shot, giving medicine to son
10. Close up, son taking medicine
11. Wide shot, son taking medicine
12. Close up, son drinking water
13. Med shot, preparing medicine
14. Wide shot, giving medicine
15. Close up, son taking medicine
FILE - UNDP - 27-29 NOVEMBER 2008
16. Wide shot, VCT center
17. Close up, medical technician checking blood samples
18. Close up, HIV rapid testing kits
19. Med shot, medical technician doing tests
20. Med shot, people living with Aids chatting
21. Close up, counselor talking to the group
22. Med shot, members of the group people living with Aids
FILE – WORLD BANK 2007, MOZAMBIQUE
23. Various shots, lab with doctors
24. Tracking shot, hallway with people sitting, waiting for treatment
25. Various shots, nurse and patients
SHOTLIST:
A new United Nations-backed report on investment in HIV prevention research in 2008 finds that funding levels for a possible vaccine for the virus have decreased for the first time since investment trends have been tracked.
The report, “Adapting to Realities: Trends in HIV Prevention Research Funding 2000 to 2008”, notes that this trend may have been influenced by shifts in scientific priorities, the global economic downturn and competition for various health issues.
Despite the decrease, the overall trend since 2000 has been of greater investment for experimental biomedical prevention strategies, adds the report, prepared by the HIV Vaccine and Microbicide Resource Tracking Working Group, of which the Joint UN Program on HIV/AIDS (UNAIDS) is a member.
It identifies investments of almost $1.2 billion in HIV prevention research in 2008, of which $868 million supported vaccine research and development (R&D), and $244 million supported microbicide R&D.
The United States was once again the leader in funding HIV prevention research, supporting 71 per cent of HIV vaccine R&D and 63 per cent of microbicide R&D in 2008.
A recent report from UNAIDS and the World Bank warned that the well-being of millions of people could be p
STORYLINE
/ VACCINE
TRT: 1.27
SOURCE: UNICEF / UNDP / WORLD BANK
RESTRICTIONS: NONE
LANGUAGE: NATS
DATELINE: FILE
SHOTLIST:
FILE – UNICEF - DECEMBER 2008, LESOTHO
1. Wide shot, exterior HIV prevention banner
2. Close up, HIV prevention banner
3. Wide shot, HIV prevention poster
4. Wide shot, street
5. Close up, hospital plate
6. Wide shot, exterior Queen Elizabeth II hospital
7. Med shot, nurse filling out medical cards
8. Close up, nurse writing
FILE – UNICEF - 23-25 NOVEMBER 2008, DOUALA AND YAOUNDE, CAMEROON
9. Wide shot, giving medicine to son
10. Close up, son taking medicine
11. Wide shot, son taking medicine
12. Close up, son drinking water
13. Med shot, preparing medicine
14. Wide shot, giving medicine
15. Close up, son taking medicine
FILE - UNDP - 27-29 NOVEMBER 2008
16. Wide shot, VCT center
17. Close up, medical technician checking blood samples
18. Close up, HIV rapid testing kits
19. Med shot, medical technician doing tests
20. Med shot, people living with Aids chatting
21. Close up, counselor talking to the group
22. Med shot, members of the group people living with Aids
FILE – WORLD BANK 2007, MOZAMBIQUE
23. Various shots, lab with doctors
24. Tracking shot, hallway with people sitting, waiting for treatment
25. Various shots, nurse and patients
SHOTLIST:
A new United Nations-backed report on investment in HIV prevention research in 2008 finds that funding levels for a possible vaccine for the virus have decreased for the first time since investment trends have been tracked.
The report, “Adapting to Realities: Trends in HIV Prevention Research Funding 2000 to 2008”, notes that this trend may have been influenced by shifts in scientific priorities, the global economic downturn and competition for various health issues.
Despite the decrease, the overall trend since 2000 has been of greater investment for experimental biomedical prevention strategies, adds the report, prepared by the HIV Vaccine and Microbicide Resource Tracking Working Group, of which the Joint UN Program on HIV/AIDS (UNAIDS) is a member.
It identifies investments of almost $1.2 billion in HIV prevention research in 2008, of which $868 million supported vaccine research and development (R&D), and $244 million supported microbicide R&D.
The United States was once again the leader in funding HIV prevention research, supporting 71 per cent of HIV vaccine R&D and 63 per cent of microbicide R&D in 2008.
A recent report from UNAIDS and the World Bank warned that the well-being of millions of people could be put at risk as HIV prevention and treatment programs fall victim to funding cutbacks as a result of the global economic crisis.
TRT: 1.27
SOURCE: UNICEF / UNDP / WORLD BANK
RESTRICTIONS: NONE
LANGUAGE: NATS
DATELINE: FILE
SHOTLIST:
FILE – UNICEF - DECEMBER 2008, LESOTHO
1. Wide shot, exterior HIV prevention banner
2. Close up, HIV prevention banner
3. Wide shot, HIV prevention poster
4. Wide shot, street
5. Close up, hospital plate
6. Wide shot, exterior Queen Elizabeth II hospital
7. Med shot, nurse filling out medical cards
8. Close up, nurse writing
FILE – UNICEF - 23-25 NOVEMBER 2008, DOUALA AND YAOUNDE, CAMEROON
9. Wide shot, giving medicine to son
10. Close up, son taking medicine
11. Wide shot, son taking medicine
12. Close up, son drinking water
13. Med shot, preparing medicine
14. Wide shot, giving medicine
15. Close up, son taking medicine
FILE - UNDP - 27-29 NOVEMBER 2008
16. Wide shot, VCT center
17. Close up, medical technician checking blood samples
18. Close up, HIV rapid testing kits
19. Med shot, medical technician doing tests
20. Med shot, people living with Aids chatting
21. Close up, counselor talking to the group
22. Med shot, members of the group people living with Aids
FILE – WORLD BANK 2007, MOZAMBIQUE
23. Various shots, lab with doctors
24. Tracking shot, hallway with people sitting, waiting for treatment
25. Various shots, nurse and patients
SHOTLIST:
A new United Nations-backed report on investment in HIV prevention research in 2008 finds that funding levels for a possible vaccine for the virus have decreased for the first time since investment trends have been tracked.
The report, “Adapting to Realities: Trends in HIV Prevention Research Funding 2000 to 2008”, notes that this trend may have been influenced by shifts in scientific priorities, the global economic downturn and competition for various health issues.
Despite the decrease, the overall trend since 2000 has been of greater investment for experimental biomedical prevention strategies, adds the report, prepared by the HIV Vaccine and Microbicide Resource Tracking Working Group, of which the Joint UN Program on HIV/AIDS (UNAIDS) is a member.
It identifies investments of almost $1.2 billion in HIV prevention research in 2008, of which $868 million supported vaccine research and development (R&D), and $244 million supported microbicide R&D.
The United States was once again the leader in funding HIV prevention research, supporting 71 per cent of HIV vaccine R&D and 63 per cent of microbicide R&D in 2008.
A recent report from UNAIDS and the World Bank warned that the well-being of millions of people could be put at risk as HIV prevention and treatment programs fall victim to funding cutbacks as a result of the global economic crisis.
Category
Topical Subjects
Corporate Subjects
Source